icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
Extension of Bulevirtide Monotherapy to 72 Weeks in HDV Patients with Compensated Cirrhosis: Efficacy and Safety From the Italian Multicenter Study (HEP4Di) Interim Analysis
 
 
  AASLD 2022 Nov 4-8
 
< MP. Anolli1, E. Degasperi1, G. D'Offizi2, MR. Brunetto3, G. Verucchi4, A. Federico5, A. Ciancio6, A. Mangia7, TA. Santantonio8, N. Coppola9, A. Pellicelli10, A. Loglio11, M. Vigaṇ12, F. Pileri13, M. Maracci14, M. Puoti15, F. Piscaglia16 and P. Lampertico1,17

1111221

1111222

1111223

1111224

1111225

1111226

1111227

1111228